513 related articles for article (PubMed ID: 11583303)
21. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
[TBL] [Abstract][Full Text] [Related]
22. [Staphylokinase--a specific plasminogen activator].
Rozpończyk E; Szemraj J; Malinowski M; Rozpończyk J
Postepy Biochem; 2006; 52(1):80-6. PubMed ID: 16869305
[TBL] [Abstract][Full Text] [Related]
23. [Thrombolytic agents].
Nagao T
Nihon Rinsho; 2014 Jul; 72(7):1254-7. PubMed ID: 25163317
[TBL] [Abstract][Full Text] [Related]
24. Real-time measurement of lysis of mural platelet deposits by fibrinolytic agents under arterial flow.
Graham DA; Huang TC; Keyt BA; Alevriadou BR
Ann Biomed Eng; 1998; 26(4):712-24. PubMed ID: 9662163
[TBL] [Abstract][Full Text] [Related]
25. Fibrinolytic agents: mechanisms of activity and pharmacology.
Lijnen HR; Collen D
Thromb Haemost; 1995 Jul; 74(1):387-90. PubMed ID: 8578491
[TBL] [Abstract][Full Text] [Related]
26. [Characteristics of the fibrinolytic system in the newborn].
Schlegel N; Hurtaud-Roux MF; Beaufils F
Ann Pediatr (Paris); 1993 Feb; 40(2):70-4. PubMed ID: 8457135
[TBL] [Abstract][Full Text] [Related]
27. Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.
Ueshima S; Matsuno H; Hayashi M; Horibuchi K; Okada K; Fukao H; Uematsu T; Matsuo O
Thromb Haemost; 2002 Jun; 87(6):1069-74. PubMed ID: 12083488
[TBL] [Abstract][Full Text] [Related]
28. [New methods of thrombolysis].
Vinazzer H
Wien Med Wochenschr; 1987 Jun; 137(10-11):221-4. PubMed ID: 2955574
[TBL] [Abstract][Full Text] [Related]
29. Pre-clinical studies of plasmin: superior benefit-to-risk ratio of plasmin compared to tissue plasminogen activator.
Marder VJ
Thromb Res; 2008; 122 Suppl 3(Suppl 3):S9-S15. PubMed ID: 18722003
[TBL] [Abstract][Full Text] [Related]
30. The effect of 40 kHz ultrasound on tissue plasminogen activator-induced clot lysis in three in vitro models.
Pieters M; Hekkenberg RT; Barrett-Bergshoeff M; Rijken DC
Ultrasound Med Biol; 2004 Nov; 30(11):1545-52. PubMed ID: 15588966
[TBL] [Abstract][Full Text] [Related]
31. Vampire bat salivary plasminogen activator evokes minimal bleeding relative to tissue-type plasminogen activator as assessed by a rabbit cuticle bleeding time model.
Mellott MJ; Ramjit DR; Stabilito II; Hare TR; Senderak ET; Lynch JJ; Gardell SJ
Thromb Haemost; 1995 Mar; 73(3):478-83. PubMed ID: 7545321
[TBL] [Abstract][Full Text] [Related]
32. Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin.
Hunt JA; Petteway SR; Scuderi P; Novokhatny V
Thromb Haemost; 2008 Sep; 100(3):413-9. PubMed ID: 18766256
[TBL] [Abstract][Full Text] [Related]
33. Comparison of intrathecally administered urokinase, tissue-type plasminogen activator, and combination of urokinase and lysine-plasminogen for clot lysis after experimental subarachnoid hemorrhage in dogs.
Kajimoto Y; Ohta T; Kuroiwa T
Neurosurgery; 1997 Mar; 40(3):572-7. PubMed ID: 9055298
[TBL] [Abstract][Full Text] [Related]
34. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
35. The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity.
Echart CL; Graziadio B; Somaini S; Ferro LI; Richardson PG; Fareed J; Iacobelli M
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):627-34. PubMed ID: 19809307
[TBL] [Abstract][Full Text] [Related]
36. Clinical pharmacology of coronary thrombolysis.
Tiefenbrunn AI; Robison AK; Sobel BE
Cardiol Clin; 1987 Feb; 5(1):125-8. PubMed ID: 3103917
[TBL] [Abstract][Full Text] [Related]
37. A multiparameter test of clot formation and fibrinolysis for in-vitro drug screening.
Kostka B; Para J; Sikora J
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):611-8. PubMed ID: 17890947
[TBL] [Abstract][Full Text] [Related]
38. [The fibrinolytic system and its activators].
Seifried E
Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
[TBL] [Abstract][Full Text] [Related]
39. Development of catheter-directed intrathrombus thrombolysis with plasmin for the treatment of acute lower extremity arterial occlusion.
Comerota AJ
Thromb Res; 2008; 122 Suppl 3():S20-6. PubMed ID: 18701142
[TBL] [Abstract][Full Text] [Related]
40. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children.
Gupta AA; Leaker M; Andrew M; Massicotte P; Liu L; Benson LN; McCrindle BW
J Pediatr; 2001 Nov; 139(5):682-8. PubMed ID: 11713447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
